| Science communication reconsidered T Bubela, MC Nisbet, R Borchelt, F Brunger, C Critchley, E Einsiedel, ... Nature biotechnology 27 (6), 514-518, 2009 | 630 | 2009 |
| Do the print media “hype” genetic research? A comparison of newspaper stories and peer-reviewed research papers TM Bubela, TA Caulfield Cmaj 170 (9), 1399-1407, 2004 | 413 | 2004 |
| ISSCR guidelines for stem cell research and clinical translation: the 2021 update R Lovell-Badge, E Anthony, RA Barker, T Bubela, AH Brivanlou, ... Stem cell reports 16 (6), 1398-1408, 2021 | 253 | 2021 |
| The global landscape of stem cell clinical trials MD Li, H Atkins, T Bubela Regenerative medicine 9 (1), 27-39, 2014 | 196 | 2014 |
| Post-publication sharing of data and tools PN Schofield, T Bubela, T Weaver, L Portilla, SD Brown, JM Hancock, ... Nature 461 (7261), 171-173, 2009 | 186 | 2009 |
| Reproducibility and reuse of adaptive immune receptor repertoire data F Breden, ET Luning Prak, B Peters, F Rubelt, CA Schramm, CE Busse, ... Frontiers in immunology 8, 1418, 2017 | 103 | 2017 |
| Role and reality: technology transfer at Canadian universities TM Bubela, T Caulfield Trends in biotechnology 28 (9), 447-451, 2010 | 89 | 2010 |
| “If they tell me to get it, I’ll get it. If they don’t....”: Immunization decision-making processes of immigrant mothers SP Kowal, CG Jardine, TM Bubela Canadian Journal of Public Health 106, e230-e235, 2015 | 88 | 2015 |
| Reflections on the cost of" low-cost" whole genome sequencing: framing the health policy debate T Caulfield, J Evans, A McGuire, C McCabe, T Bubela, R Cook-Deegan, ... PLoS biology 11 (11), e1001699, 2013 | 88 | 2013 |
| Responsible translation of stem cell research: an assessment of clinical trial registration and publications M Fung, Y Yuan, H Atkins, Q Shi, T Bubela Stem Cell Reports 8 (5), 1190-1201, 2017 | 84 | 2017 |
| Patent landscaping for life sciences innovation: toward consistent and transparent practices T Bubela, ER Gold, GD Graff, DR Cahoy, D Nicol, D Castle Nature Biotechnology 31 (3), 202-206, 2013 | 77 | 2013 |
| Myriad and the mass media: the covering of a gene patent controversy T Caulfield, T Bubela, CJ Murdoch Genetics in Medicine 9 (12), 850-855, 2007 | 75 | 2007 |
| Is belief larger than fact: expectations, optimism and reality for translational stem cell research T Bubela, MD Li, M Hafez, M Bieber, H Atkins BMC medicine 10, 1-10, 2012 | 74 | 2012 |
| Science communication in transition: genomics hype, public engagement, education and commercialization pressures T Bubela Clinical genetics 70 (5), 445-450, 2006 | 73 | 2006 |
| Paving the road to personalized medicine: recommendations on regulatory, intellectual property and reimbursement challenges L Knowles, W Luth, T Bubela Journal of Law and the Biosciences 4 (3), 453-506, 2017 | 71 | 2017 |
| Prospects for scaling‐up supervised injection facilities in C anada: the role of evidence in legal and political decision‐making E Hyshka, T Bubela, TC Wild Addiction 108 (3), 468-476, 2013 | 66 | 2013 |
| Author name disambiguation for collaboration network analysis and visualization A Strotmann, D Zhao, T Bubela Proceedings of the American Society for Information Science and Technology …, 2009 | 65 | 2009 |
| Bringing regenerative medicines to the clinic: the future for regulation and reimbursement T Bubela, C McCabe, P Archibald, H Atkins, SE Bradshaw, P Kefalas, ... Regenerative medicine 10 (7), 897-911, 2015 | 64 | 2015 |
| Let’s do better: public representations of COVID-19 science T Caulfield, T Bubela, J Kimmelman, V Ravitsky Facets 6 (1), 403-423, 2021 | 62 | 2021 |
| Diet of two sympatric Australian subalpine rodents, Mastacomys fuscus and Rattus fuscipes PL Carron, DCD Happold, TM Bubela Australian Wildlife Research 17, 479-489, 1990 | 62 | 1990 |
